首页 正文

Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma

{{output}}
Background: Neuroblastoma (NB) is a childhood cancer with a high relapse rate despite intensive treatment. TRPA1 is a pain-sensing ion channel with downstream impacts on proliferative and pro-apoptotic pathways. Here, we evaluate... ...